Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Non-Current Assets (2020 - 2026)

GeneDx Holdings has reported Non-Current Assets over the past 7 years, most recently at $235.7 million for Q1 2026.

  • Quarterly Non-Current Assets rose 6.83% to $235.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Mar 2026, up 12.86% year-over-year, with the annual reading at $255.4 million for FY2025, 15.36% up from the prior year.
  • Non-Current Assets was $235.7 million for Q1 2026 at GeneDx Holdings, down from $255.4 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $530.6 million in Q2 2022 and troughed at $107.2 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $245.5 million (2023), against an average of $269.8 million.
  • Year-over-year, Non-Current Assets soared 705.55% in 2022 and then tumbled 53.01% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $278.3 million in 2022, then decreased by 15.06% to $236.4 million in 2023, then dropped by 6.35% to $221.4 million in 2024, then rose by 15.36% to $255.4 million in 2025, then dropped by 7.73% to $235.7 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Non-Current Assets are $235.7 million (Q1 2026), $255.4 million (Q4 2025), and $256.3 million (Q3 2025).